Total consideration for the acquisition of BAHS, including $96.1 million of value for noncontrolling interests, was $351.1 million, summarized as follows: Net cash consideration paid by Henry Schein, Inc. | | $ | 41,990 | | Net book value of the United States animal health operations' assets and liabilities contributed | | | 86,048 | | Fair value of noncontrolling interest in BAHS | | | 96,110 | | Incremental debt incurred | | | 127,000 | | Total consideration | | $ | 351,148 | |
The total consideration of $351.1 million was allocated as follows: Net assets of BAHS at fair value: | | | | Current assets | | $ | 164,789 | | Intangible assets: | | | | | Trade name (useful life 3 years) | | | 10,000 | | Customer relationships (useful life 12 years) | | | 140,000 | | Non-compete agreements (useful life 2 years) | | | 2,600 | | Goodwill | | | 270,714 | | Other assets | | | 14,138 | | Current liabilities | | | (62,770 | ) | Bank indebtedness | | | (200,100 | ) | Deferred income tax liabilities | | | (74,271 | ) | Net book value of our assets and liabilities contributed | | | 86,048 | | Total allocation of consideration | | $ | 351,148 | |
|